Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03153956 · ClinicalTrials.gov registry record · NA
Efficacy of AposTherapy® in Knee OA
A NA study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT03153956 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 77 participants.
The verdict
NCT03153956, a NA study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
A prospective, interventional, randomized, double-arm clinical evaluation study to examine the efficacy of AposTherapy® versus a control group, in the short-term at 6 months and in the long-term at 12 months post-treatment, with the primary efficacy assessment based on improvement in knee pain score and improvement in function in patients following diagnosis of knee osteoarthritis (OA).
Interventions
- DEVICE Calibrated AposTherapy®
- DEVICE Non-Calibrated Sham Apos Therapy Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2015-04-16 |
| Est. Completion | 2018-11-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03153956
The ClinicalTrials.gov registry entry for NCT03153956 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Calibrated AposTherapy® is the first listed.
NCT03153956 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03153956 about?
NCT03153956 is a clinical study titled "Efficacy of AposTherapy® in Knee OA". A prospective, interventional, randomized, double-arm clinical evaluation study to examine the efficacy of AposTherapy® versus a control group, in the short-term at 6 months and in the long-term at 12 months post-treatment, with the primary efficacy assessment based on improvement in knee pain score...
What is the current status of trial NCT03153956?
This trial is currently terminated. It is a NA study. The enrollment target is 77 participants. The study started on 2015-04-16. Estimated completion is 2018-11-15.
What interventions are being tested in trial NCT03153956?
The interventions under investigation include: Calibrated AposTherapy® (DEVICE), Non-Calibrated Sham Apos Therapy Device (DEVICE).
Who is sponsoring clinical trial NCT03153956?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.